FAKTOR-OPTIONSSCHEIN - RECORDATI INDUSTRIA CHIMICA E FARMA | Real-time Bid/Ask 02:47:07 27/06/2024 pm IST | ||
| 4.23 EUR / 4.29 EUR | -6.58% |
|
| Current month | +6.54% | ||
| 1 month | +5.56% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
Latest news about RECORDATI
More news
| Date | Price | Change |
|---|---|---|
| 27/24/27 | 4.34 | -4.82% |
| 26/24/26 | 4.56 | +3.17% |
| 25/24/25 | 4.42 | -9.05% |
| 24/24/24 | 4.86 | +11.72% |
| 21/24/21 | 4.35 | +1.64% |
Delayed Quote Börse Stuttgart
Last update June 27, 2024 at 01:50 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | Morgan Stanley |
| WKN | MG157N |
| ISIN | DE000MG157N0 |
| Date issued | 27/03/2024 |
| Strike | 43.43 € |
| Maturity | Unlimited |
| Parity | 1.35 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.43 € |
|---|---|
| Lowest since issue | 3.48 € |
| Spread | 0.06 € |
| Spread % | 1.41% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
49.62
EUR
Average target price
52.64
EUR
Spread / Average Target
+6.09%
- Stock Market
- Certificates
- Certificat
